Kidney Research UK https://www.kidneyresearchuk.org/ Kidney disease ends here. Fri, 19 Dec 2025 14:32:23 +0000 en-GB hourly 1 https://wordpress.org/?v=6.9 https://www.kidneyresearchuk.org/wp-content/uploads/2018/07/cropped-kruk-favicon-1-32x32.png Kidney Research UK https://www.kidneyresearchuk.org/ 32 32 New insight into the experiences of older kidney transplant patients https://www.kidneyresearchuk.org/2025/12/19/new-insight-into-the-experiences-of-older-kidney-transplant-patients/ Fri, 19 Dec 2025 14:30:58 +0000 https://www.kidneyresearchuk.org/?p=160222 New insight into the experiences of older kidney transplant patients 19 December 2025 Recent results published in Kidney International reports, led by Professor Edwina Brown and Dr Michelle Willicombe from Imperial College London, supported by a Kidney Research UK-Stoneygate research project grant, provide important insights into the experiences of older patients receiving a kidney transplant.     More older adults are receiving kidney transplants The number of older people receiving a kidney transplant is increasing. Around 9,500 patients who were 65…

The post New insight into the experiences of older kidney transplant patients appeared first on Kidney Research UK.

]]>

New insight into the experiences of older kidney transplant patients

19 December 2025

Recent results published in Kidney International reports, led by Professor Edwina Brown and Dr Michelle Willicombe from Imperial College London, supported by a Kidney Research UK-Stoneygate research project grant, provide important insights into the experiences of older patients receiving a kidney transplant  

More older adults are receiving kidney transplants

The number of older people receiving a kidney transplant is increasing. Around 9,500 patients who were 65 and over received a kidney transplant in 2019 compared to around 10,600 in 2023.  

Frailty is more common in older patients. However, there is little research into how frailty could impact physical and mental health for transplant patients. By identifying these effects, patients and doctors would have a better understanding of what transplant surgery could mean for the individual. It could also inform interventions to better support these patients to try to protect their physical and mental health following transplant surgery.  

What is frailty?    

With age, the body may lose its built-in reserves across different body systems, meaning it is less able to recover, or bounce back, from illness and injury. This is called frailty.  

Identifying how frailty affects older people receiving a kidney transplant

Edwina, Michelle and the team looked at 210 patients over the age of 60 who were waiting for a kidney transplant. They investigated whether having frailty impacted mental and physical health in the months before and following kidney transplant surgery. This included questionnaires to assess physical and mental quality of life, symptom burden, treatment satisfaction and the impact of their condition on their everyday life. 

Edwina, Michelle and the team also looked at medical data for these patients to see if people with frailty were more at risk of health problems related to transplant surgery itself, such as infection.    

The majority of participants reported their mental and physical health decreased following surgery. Participants who were frail or vulnerable to frailty reported worse symptom burden, mental health and depression following transplant. However, for most, the burden of their symptoms and satisfaction with their treatment improved after surgery and reached a better level than before transplant by one year.  

Following transplant surgery, frail and vulnerable to frailty participants were more likely to have a kidney that took longer to begin working properly, which can mean a temporary return to dialysis, and were more likely to spend longer in hospital recovering from surgery. 

Longer term function of the transplant, measured after a year, was also not as good in frail and vulnerable to frailty participants. However, in most cases a kidney transplant did stabilise the declining physical health of people who were frail and vulnerable to frailty. 

Professor Edwina Brown
Professor Edwina Brown

What could this mean for patients?

By understanding better how frailty affects outcomes for older transplant patients, we can provide healthcare professionals and patients with more information on what a kidney transplant could mean for the individual. This could also inform more targeted support for these patients in managing both their physical and mental health following transplant surgery.  

“These results have given us new insight on the many impacts on both physical and mental health for older patients undergoing kidney transplant surgery.

“We want patients to have the most information to help them make a decision that is right for them, and as healthcare professionals we want to do our best to support these patients. Having a clearer picture of what a kidney transplant could mean for the individual is key to this.” Professor Edwina Brown 

Read about our latest research

Why not make a donation now?

Every £ counts towards transforming treatments for people living with kidney disease.

The post New insight into the experiences of older kidney transplant patients appeared first on Kidney Research UK.

]]>
Could understanding blood pressure changes during sleep in kidney patients be key to protecting heart and vessel health? https://www.kidneyresearchuk.org/2025/12/16/could-understanding-blood-pressure-changes-during-sleep-in-kidney-patients-be-key-to-protecting-heart-and-vessel-health/ Tue, 16 Dec 2025 17:22:40 +0000 https://www.kidneyresearchuk.org/?p=160209 Could understanding blood pressure changes during sleep in kidney patients be key to protecting heart and vessel health? 16 December 2025 In a study published in Cardiovascular Research, Dr Jess Ivy and the team at the University of Edinburgh, with funding from Kidney Research UK, have shown that studying changes in small blood vessels in the kidney in models during sleep could improve our understanding of heart…

The post Could understanding blood pressure changes during sleep in kidney patients be key to protecting heart and vessel health? appeared first on Kidney Research UK.

]]>

Could understanding blood pressure changes during sleep in kidney patients be key to protecting heart and vessel health?

16 December 2025

In a study published in Cardiovascular Research, Dr Jess Ivy and the team at the University of Edinburgh, with funding from Kidney Research UK, have shown that studying changes in small blood vessels in the kidney in models during sleep could improve our understanding of heart and vessel health in kidney disease patients.  

Three researchers in the lab wearing white coats with microscopes on the bench in front of them.
Jess Ivy, Georgios Krilis and Anastasiia Komolova in the lab

How does blood pressure change during sleep?

Usually, blood pressure is lower when asleep than when awake. This is part of the body’s natural rhythm. However, people with chronic kidney disease (CKD) are more likely to have blood pressure that doesn’t decrease during sleep, which is called non-dipping blood pressure. Non-dipping blood pressure is thought to be worse for heart and blood vessel health, and increases the risk of a cardiovascular event, such as a heart attack or stroke.  

How could steroid hormones change blood pressure during sleep?

The body produces many naturally occurring hormones, this includes steroid hormones. Glucocorticoids are a steroid hormone essential for normal bodily functions and their levels vary throughout the day.  

In laboratory models, altering the natural levels of glucocorticoids can trigger non-dipping blood pressure. Steroids, which are artificial versions of the body’s natural glucocorticoids, are widely used medicines to help reduce inflammation (part of the body’s defence system) in conditions where it is damaging the body’s own tissues. People living with long term conditions, such as diabetes, can also have changes to the body’s natural levels of glucocorticoids.  

A closer look at glucocorticoids and kidney vessels 

Jess and the team have been studying the effect of glucocorticoids on the small tubes which carry blood into the kidney, called the renal arteries. Widening and narrowing of the renal arteries controls the blood flow into the kidney, which is an important mechanism for helping the kidneys to control blood pressure.   

To test the effect of glucocorticoids on the renal arteries, Jess and the team gave a laboratory model continuous glucocorticoids, to reduce its natural rhythm. They found that in this model the renal arteries lost their normal pattern of widening and narrowing while awake or asleep. They also found that different genes, which are small sections of DNA, were switched on and off in different rhythms. These changes to the widening and narrowing of the renal arteries, and the genes switched on and off, showed model renal arteries respond to rhythmic glucocorticoid levels, which could then influence blood pressure control by the kidney. 

What could this mean for kidney patients?  

By looking at the effect of glucocorticoid levels on the kidneys, we could increase understanding of the mechanisms behind blood pressure changes during sleep. This could lead to new ways of protecting the vessel health of kidney patients in the future and form a new approach to improving cardiovascular health.  

David Crosby, chief research officer at Kidney Research UK commented: “We need to find new ways of protecting cardiovascular health in kidney patients who are at an increased risk of having an event such as a heart attack, heart failure or stroke. This new approach to better understand how blood pressure changes during sleep could potentially inform new ways of protecting cardiovascular health in kidney patients. More research is needed to develop this concept, and we look forward to the next steps.” 

* This is an experimental study and no changes to medications should be made without advice from a healthcare professional. 

Kidney Kit bundle

Have you been diagnosed with kidney disease?

Request your free Kidney Kit today.

You'll find tips and support from kidney patients, delicious recipes, simple exercise plans and more.

Why not make a donation now?

Every £ counts towards transforming treatments for people living with kidney disease.

The post Could understanding blood pressure changes during sleep in kidney patients be key to protecting heart and vessel health? appeared first on Kidney Research UK.

]]>
Remembering Elvis-obsessed dad who died last Christmas https://www.kidneyresearchuk.org/2025/12/16/remembering-elvis-obsessed-dad-who-died-last-christmas/ Tue, 16 Dec 2025 16:40:35 +0000 https://www.kidneyresearchuk.org/?p=160202 Remembering Elvis-obsessed dad who died last Christmas 16 December 2025 A family from Telford will spend Christmas without their beloved dad, grandad and husband, who was affectionately known as ‘Elvis’ because of his love of ‘The King of rock 'n' roll’.  Elvis - real name Roy Owen-Jones - was 82 years old when he passed away on 29 December 2024 after a blockage in his kidney.   His son, Darren, said: “It will be strange…

The post Remembering Elvis-obsessed dad who died last Christmas appeared first on Kidney Research UK.

]]>

Remembering Elvis-obsessed dad who died last Christmas

16 December 2025

A family from Telford will spend Christmas without their beloved dad, grandad and husband, who was affectionately known as ‘Elvis’ because of his love of ‘The King of rock 'n' roll’. 

Elvis - real name Roy Owen-Jones - was 82 years old when he passed away on 29 December 2024 after a blockage in his kidney.  

His son, Darren, said: “It will be strange this Christmas without him. All of the big occasions without him for the first time have been tough. My mum and dad were together for 55 years, so it has been extremely difficult for her. She misses him a lot and is just trying to get through day by day. 

“We didn’t celebrate Christmas last year because Dad was in hospital. This year we’ve tried to encourage mum to put up a tree and some decorations. We’ll all be together at Christmas to support her and each other through it.” 

Dad kneeling down next to small girl.
Roy Owen-Jones

Kidney problems

Roy first experienced problems with his kidneys in the mid-1990s when he needed to have one removed due to damage in childhood. His kidney health worsened in the mid-2000s when he was diagnosed with prostate cancer and emphysema. 

Darren said: “Dad was a very proud man and wouldn’t accept much help from others as his health deteriorated. He didn’t like speaking about it and kept a lot of details private, even from me and my mum.   

“He was very young at heart and before he became seriously ill in his sixties, he was very active. He was really into his sport and a keen gardener. However, in the last ten years of his life he couldn’t get out and about as much. Mum became his carer as his mobility worsened, and he became very frustrated. 

“He had kidney stones but didn’t tell anyone until he collapsed with a blockage in his kidney. He spent three months in hospital before he died. It was hard seeing him suffer. Doctors tried multiple operations but couldn’t save his life.” 

Male and female running dressed as Elvis in white outfits.
Darren and daughter Megan

Elvis-inspired fundraiser

In March, Darren and his daughter, Megan, transformed themselves into Elvis - wearing fancy dress to run the Ironbridge Half Marathon. Together they raised over £1,000 for kidney research. 

Darren said: “After Dad died, we wanted to give something back to help improve treatments for other patients. My daughter and I are both runners, and she suggested we take part in the half marathon for Kidney Research UK.  

“We wanted to make the challenge personal, so decided to dress up as Elvis. Dad was obsessed with him and thought he looked similar – even though he didn’t! He copied the famous hairstyle, dying his hair jet back, and dressed flamboyantly. He owned loads of Elvis memorabilia, and we had plenty of Elvis-related tributes at his funeral. 

“The fancy dress made the run a little trickier, but not too bad! It was amazing to receive so much support and raise the amount we did.” 

You can support kidney patients to have better outcomes in the future.

Donate today to transform lives.

The post Remembering Elvis-obsessed dad who died last Christmas appeared first on Kidney Research UK.

]]>
Kidney transplanted using world-first technique still going strong after 15 years https://www.kidneyresearchuk.org/2025/12/16/kidney-transplanted-using-world-first-technique-still-going-strong-after-15-years/ Tue, 16 Dec 2025 08:00:01 +0000 https://www.kidneyresearchuk.org/?p=160186 Kidney transplanted using world-first technique still going strong after 15 years 16 December 2025 A woman from Lincoln has been reunited with the surgeon who performed a first-of-its-kind kidney transplant 15 years ago.  In 2010, Deborah Bakewell, 70, became the first person in the world to be given a kidney using a technique called normothermic…

The post Kidney transplanted using world-first technique still going strong after 15 years appeared first on Kidney Research UK.

]]>

Kidney transplanted using world-first technique still going strong after 15 years

16 December 2025

A woman from Lincoln has been reunited with the surgeon who performed a first-of-its-kind kidney transplant 15 years ago. 

In 2010, Deborah Bakewell, 70, became the first person in the world to be given a kidney using a technique called normothermic machine perfusion. This pioneering technique was developed by Professor Mike Nicholson, who was also the surgeon for Deborah’s kidney transplant. 

A special reunion

Professor Nicholson and Deborah had an emotional reunion in December at his lab at Addenbrookes Hospital in Cambridge, as they reflected on the difference the transplant has made for Deborah over the past 15 years. 

Deborah says: “I thought I was going to burst into tears as soon as I saw him again. He is my hero. Before my transplant I spent three years dialysing nine hours a night, seven nights a week. That meant I was in bed at 7.30pm, connected to a machine and was stuck there all night. It was so frustrating having my life restricted by a dialysis machine.  

“When I was on the transplant list, I was worried I’d never get a kidney because of the shortage of donors. I didn’t know if I’d ever get to have a normal life again. Thankfully, because of this normothermic machine perfusion technique, I had the opportunity to receive a kidney which would not previously have been selected for transplantation. 

“It has already given me 15 wonderful years, spending time with my step-grandchildren, travelling and playing golf. That would not have been possible without my transplant. I cannot express how thankful I am to my donor and Professor Mike Nicholson.” 

Male and female in a research lab, hugging.
Deborah reunited with Professor Mike Nicholson

What is normothermic perfusion?

A technique revolutionising kidney transplant surgery, developed from research conducted by Professor Mike Nicholson and funded by Kidney Research UK. 

The donor kidney is connected to a machine that flushes the organ with oxygenated blood. This technique allows doctors to test whether a marginal kidney is suitable for a patient, when previously it may not have been considered viable. 

Normothermic machine perfusion is also being investigated as a way of delivering medications that could one day improve the health or lifespan of a donated kidney. Research in this area is continuing to be developed by Professor Sarah Hosgood from the University of Cambridge, who we’ve funded to investigate whether stem cells from the urine of premature babies could be used to improve the condition of kidneys from older donors for transplant.   

Deborah Bakewell and husband at Christmas
Deborah Bakewell and husband Bryan.

Hereditary kidney disease

Polycystic kidney disease (PKD)has affected many of Deborah’s family members, including her mother, grandmother and nephew. At 23, she found out she’d also inherited the condition, which causes fluid-filled cysts to form in the kidneys.  

Deborah says: “It didn’t affect me significantly until I was in my 40s, but by the time I’d reached my early 50s I had no choice but to start dialysis treatment. My kidneys had failed and I was exhausted. 

“My life changed drastically, and I tried to hold on to whatever normality I could by continuing in my job at Belvoir Lettings. Dialysing increased my energy levels, but having to do it for several hours, each night, disrupted every occasion. Dialysis was dictating my life. 

“My husband, Bryan, was tested to become a living donor, but unfortunately his own health circumstances meant he was not eligible to donate a kidney. I spent three years on the kidney transplant waiting list, wondering if it was ever going to happen for me.” 

Receiving a kidney transplant

In 2010, Deborah was given the opportunity to be the first person in the world to receive a kidney transplant using the normothermic machine perfusion technique.  

She says: “When I was approached about having the transplant, I felt I had nothing to lose. The kidney had been rejected for transplantation by other hospitals because of concerns over the quality of the organ, but I was desperate for the chance to escape dialysis.  

“Professor Nicholson’s research enabled his team to test the kidney’s function to ensure it was suitable for transplantation. Even though I was the first having a transplant using normothermic machine perfusion, I trusted him and his team. Someone had to be first and I’m so glad it was me! 

“I’ve had a wonderfully normal life over the past 15 years, and that’s all you can ever hope for. Normality should be valued. It’s something that was quickly taken away from me when I was on dialysis. There are so many simple things I treasure now, such as getting fish and chips, or going for a weekend away.  

“I have written to the donor’s family, both immediately after my transplant and ten years later. I cannot express how thankful I am.” 

Celebrating my kidneyversary

A transplant from a deceased donor lasts 15-20 years on average, and Deborah has now reached that milestone.  

She says: “Reaching 15 years is fantastic, particularly when you consider that the kidney would not have been considered viable for transplantation without Professor Nicholson’s research. 

“I know a transplant is only a treatment, and that one day I might need dialysis again. However, I hope over the next 15 years I’ll still be here to see my step-grandchildren grow and flourish. The youngest is in nursery and the eldest is in year ten. I’d love to see them reach adulthood.  

Reflecting on the anniversary of her transplant is important to Deborah, as it is for many patients who receive an organ. She says: “Bryan and I go for a quiet meal every kidneyversary to remember my donor and appreciate another year of life with my kidney. 

Deborah standing on a holiday apartment balcony, with a sunny village behind her.
Deborah on holiday

“This year it has been special to reunite with Professor Nicholson. We also joined Kidney Research UK’s Christmas Carol Concert, where I shared my experiences with PKD as part of the service. It was a great occasion. 

“I hope people consider becoming organ donors after hearing the difference that has been made to my life. I carry a donor card in the hope that, after I die, I can still make a positive difference to someone else’s life with whatever organs are suitable to be transplanted. 

“I would love to see research continue to evolve, making even more life-changing transplants possible. Researchers like Professor Nicholson and his team are absolutely brilliant, and the fact the normothermic machine perfusion technique is being further developed is fantastic.” 

Our life-saving research is only possible with your support.

Make a gift today to fund more research for tomorrow.

The post Kidney transplanted using world-first technique still going strong after 15 years appeared first on Kidney Research UK.

]]>
New blood marker can predict individuals most at risk of kidney failure https://www.kidneyresearchuk.org/2025/12/15/new-blood-marker-can-predict-individuals-most-at-risk-of-kidney-failure/ Mon, 15 Dec 2025 16:45:29 +0000 https://www.kidneyresearchuk.org/?p=160193 New blood marker can predict individuals most at risk of kidney failure 15 December 2025 In a study published recently in Nature Communications, Dr Laura Denby and collaborators at the University of Edinburgh and Queen’s University Belfast, with funding from Kidney Research UK, have discovered a new biomarker in the blood for chronic kidney disease (CKD). This marker identified patients at a higher risk of faster chronic kidney disease progression, which in the future could be used to inform earlier interventions to…

The post New blood marker can predict individuals most at risk of kidney failure appeared first on Kidney Research UK.

]]>

New blood marker can predict individuals most at risk of kidney failure

15 December 2025

In a study published recently in Nature CommunicationsDr Laura Denby and collaborators at the University of Edinburgh and Queen’s University Belfastwith funding from Kidney Research UK, have discovered a new biomarker in the blood for chronic kidney disease (CKD). This marker identified patients at a higher risk of faster chronic kidney disease progression, which in the future could be used to inform earlier interventions to help protect kidney health 

What are the tests for kidney function?

CKD is usually diagnosed with a blood test, to measure the level of creatinine, and a urine test, to look at the level of protein. Higher levels of these markers suggest reduced kidney function, which is used to identify the stage of CKD and inform any interventions, such as lifestyle changes, medications, dialysis and transplant.   

What is microRNA?

MicroRNAs (miRNAs) are small molecules that are guardians of whether or not certain proteins are made from the instructions contained in our DNA. They are found throughout the body, including in the kidneys. 

Better tests are needed to identify patients at risk of CKD progression 

For patients with CKD, normal levels of creatinine in the blood and low protein in the urine can indicate that their kidneys appear to be working well and their risk of disease of progression low. However, CKD has many different causes and will affect patients differently.

Some patients with CKD can have no or little protein in their urine but still go on to lose kidney function and in some cases reach kidney failure. By identifying these at-risk patients early, this new biomarker could support the most appropriate treatments for their long-term kidney health. 

Blood microRNA predicts CKD progression

Laura and the team began by looking at the genes expressed in blood samples of 33 patients with type 2 diabetes. They found a specific type of microRNA, called miR-190a-5p, was lower in patients who had worse kidney function. 

By testing the levels of this miRNA in a larger group of 298 patients with CKD, they were able to identify lower levels in patients with worse kidney function, this time due to a variety of causes. When they followed up these patients around four years later, they found that amongst patients who would normally be considered at low risk of CKD progression as they had a low or medium level of protein in the urine, those with a lower miR-190a-5p blood level, had an increased risk of CKD progression, with some patients reaching kidney failure by this time. 

Laura and her collaborators then went on to look at where miR-190a-5p is found and what role it could have in the kidney. By examining 24 biopsy samples they could look at how much miR-190a-5p was present in the kidney. They found that lower levels were seen in biopsy samples with more scarring and fewer/smaller tubules (tiny tubes important for producing urine in the kidney). Using a laboratory model they found restoring the levels of miR-190a-5p in kidney injury both reduced scarring and improved kidney health.  

What could this mean for patients?

This new blood marker could in the future help healthcare providers to identify patients with a high likelihood of CKD progression, who may not be identified using current kidney function tests. 

This could mean more regular monitoring, and earlier interventions for these patients, such as medications to try and protect kidney health and slow the progression of CKD. 

In the longer term, therapies could be developed to restore the level of miR-190-5p in the kidneys of patients with CKD which may reduce renal scarring and preserve kidney function. 

Black background, female wearing a black top, and red hair, smiling for a portrait shot
Dr Laura Denby

“This research has been supported by Kidney Research UK throughout its journey, from discovery of this microRNA molecule in the lab, to translating this into patients.

"My interest in miRNAs goes back to my post-doctoral fellowship, and the CKD patient samples used in this study came from seNSOR, both of these projects as well as my senior fellowship were funded by Kidney Research UK.

"We’re now at the stage where these results could inform better testing for CKD and improve things for patients which is why I do the research I’m doing.

"I am very grateful to Kidney Research UK’s supporters for making this possible.” Dr Laura Denby  

 

Kidney Kit bundle

Have you been diagnosed with kidney disease?

Request your free Kidney Kit today.

You'll find tips and support from kidney patients, delicious recipes, simple exercise plans and more.

Why not make a donation now?

Every £ counts towards transforming treatments for people living with kidney disease.

The post New blood marker can predict individuals most at risk of kidney failure appeared first on Kidney Research UK.

]]>
Looking back at 2025: research highlights https://www.kidneyresearchuk.org/2025/12/12/looking-back-at-2025-research-highlights/ Fri, 12 Dec 2025 14:33:32 +0000 https://www.kidneyresearchuk.org/?p=160160 Looking back at 2025: research highlights 12 December 2025 As 2025 draws to a close, we reflect on a year filled with promising new grants and exciting research findings. Here we share some of our research highlights from the year.    These successes would not have been possible without our amazing supporters and researchers, so thank you for making it happen.  We look forward…

The post Looking back at 2025: research highlights appeared first on Kidney Research UK.

]]>

Looking back at 2025: research highlights

12 December 2025

As 2025 draws to a close, we reflect on a year filled with promising new grants and exciting research findings. Here we share some of our research highlights from the year.   

These successes would not have been possible without our amazing supporters and researchers, so thank you for making it happen.  We look forward to another year of driving discoveries and making them count to improve the lives of people living with and at risk of kidney disease. 

Read about the research we've been funding with your support. 

The research team, two females and two males, standing together in their research lab.
Research team (L-R) Rachel Bell, Laura Denby, Max Reck and Bryan Conway.

Research identifies new treatment targets to halt loss of kidney function

In June, we shared results from a study led by Dr Bryan Conway at the University of Edinburgh, funded by Kidney Research UK. The team identified a group of kidney cells that emerge after chronic kidney disease (CKD) or acute kidney injury (AKI) and contribute to the loss of kidney function. They also uncovered two promising treatment targets that could stop AKI progressing to CKD and slow kidney decline in people already diagnosed. By revealing how healthy kidney cells are lost following injury, this research could guide the development of new treatments that protect patients from long-term loss of kidney function after AKI. 

A male, dressed in blue hospital scrubs, in a operating room surrounded by equipment and a computer next to him,
Mr James Bennett

Could filtering blood remove a toxic substance and protect the kidneys during surgery? 

Mr James Bennett, a clinical perfusion scientist at Liverpool Heart and Chest Hospital, received a Kidney Research UK allied health professional fellowship to support his PhD at the University of Liverpool. His research focuses on developing a specialised filter to remove a kidney-toxic substance released by damaged red blood cells during certain types of surgery. By better understanding how the kidneys are impacted by damaged red blood cells and developing a new type of medical filter to remove the toxic product, James’ work could inform interventions to reduce the risk of AKI for patients undergoing surgery in the future. 

Medical worker carrying a box which say human organ on the side.

Identifying new treatments for cytomegalovirus (CMV) after kidney transplant 

Dr Emma Poole, from the University of Cambridge, received a Professor Michael Nicholson Research Project Award with Dr Sarah Hosgood, Professor Michael Nicholson (University of Cambridge) and Dr Michael Nevels (University of St Andrew’s). The funding award will enable them to test new compounds that may inactivate CMV in donor kidneys, reducing the risks associated with CMV infection in kidney transplant patients and keeping donated kidneys healthier, for longer. 

Professor Alan Salama
Professor Alan Salama

Personalising treatments for focal and segmental glomerulosclerosis patients receiving a kidney transplant 

Professor Alan Salama from University College London received a Kidney Research UK and Stoneygate funded Professor Michael Nicholson research project grant to develop a new test to detect the presence of harmful proteins or other compounds (known as factors) to the kidneys in patients with focal and segmental glomerulosclerosis (FSGS). This will enable a better understand FSGS causes and which treatments may be most effective, with the aim of preventing FSGS from recurring after a transplant. In the future, a blood test to detect these factors could be used to screen patients before surgery, allowing doctors to remove them and better protect transplanted kidneys. 

A female healthcare profession sat at her desk.
Cathy Pogson

Protecting people with vulnerable kidneys with medication reviews 

Mrs Cathy Pogson from Portsmouth Hospitals NHS Trust received an allied health professional fellowship funded by Kidney Research UK, Pharmacy Research UK and the UK Kidney Association. Cathy will develop a medication review system specific to patients with decreased kidney function who are taking multiple medications. A specialist medication review could improve safety and reduce harm from medicines, minimise the burden of taking many medicines and improve quality of life. If effective, it could also inform future studies to trial the review more widely across different hospitals 

Daniel, standing outside in front of a building, wearing a suit and glasses.
Dr Daniyal Jafree

The role of the lymphatic system in kidney transplantation: is it good or bad?   

With funding from Kidney Research UK, Dr Daniyal Jafree and Professor David Long together with researchers at UCL, the University of Cambridge and the Wellcome Sanger Institute shared results highlighting the kidney’s lymphatic vessels as an important part of the human kidney, and as active players in kidney transplant rejection. This new 3D imaging technique used here is now being applied across several other models of kidney disease and biopsies from patients, to detect changes in lymphatics at a much faster rate and understand the mechanisms that underly rejection.   

a tray of test tubes

Can we make the switch from kidney damage to repair? 

Dr Irina Grigorieva from Cardiff University was awarded the Iris Bruton Award in partnership with Kidney Research UK to look at how a type of kidney cell could promote healing and repair to improve kidney function. By identifying which groups of cells support growth and repair, which cause scarring and understanding the underlying mechanisms, new treatment targets could be identified to try and prevent damage to the kidneys. This award will enable Irina to undertake a fellowship to progress her research career, while contributing valuable information to help identify new treatments for people with kidney disease.

Man standing side on at a research lab bench holding research instrument. He's wearing a blue lab coat and blue gloves.
Mr George Nita

Could a new blood test identify rejection earlier in kidney transplant patients? 

Mr George Nita, surgeon from the Royal Liverpool University Hospital, and researcher in bioinformatics at the University of Liverpool, received the Kidney Research UK and Stoneygate funded Professor Michael Nicholson transplant surgeon doctoral fellowship award to look at whether a new type of blood test can identify kidney transplant rejection early. This could mean earlier interventions to help protect a new kidney from damage, and in some cases eliminate the need for biopsies which carry some risk.    

Male sat on a brown leather sofa, draping his hands over the side. He is wearing a pale blue shirt and brown suit style jacket.
Professor Colin A Johnson

Research looking at repurposing drugs to treat polycystic kidney disease shows promising new results 

Earlier this year, we shared results from Professor Colin A Johnson and researchers at the University of Leeds and University of Sheffield, who received a grant from Kidney Research UK and the PKD Charity. This group have identified disease pathways in polycystic kidney disease (PKD) and shown that they can be targeted with existing drugs, aiming to get new treatments to patients faster. Following the promising results seen in this study, Colin and the team are keen to carry out additional experiments in pre-clinical models to gather as much data as possible before progressing the treatments to clinical studies  

Headshot of Sarah wearing a sleeveless high neck top and long hair.
Professor Sarah Howles

Research uncovers genetic changes linked to developing kidney stones 

Professor Sarah Howles and her team at the University of Oxford, with funding from Kidney Research UK, have discovered DNA changes that likely control people’s calcium and phosphate levels and cause kidney stones.Treating patients with existing drugs and supplements that affect calcium and phosphate levels could reduce the risk of stones forming by up to 90%. This research could enable future tests that allow a personalised approach to kidney stones by using medications that target genetic changes.      

Want to stay up to date with the latest research?

Sign up to our regular email to get all the research news, ways to get involved and kidney health advice.

The post Looking back at 2025: research highlights appeared first on Kidney Research UK.

]]>
Could a new blood test identify rare blood cancer sooner in people with kidney transplants? https://www.kidneyresearchuk.org/2025/12/10/could-a-new-blood-test-identify-rare-blood-cancer-sooner-in-people-with-kidney-transplants/ Wed, 10 Dec 2025 11:29:43 +0000 https://www.kidneyresearchuk.org/?p=160114 Could a new blood test identify rare blood cancer sooner in people with kidney transplants? 10 December 2025 How do rare blood cancers develop after transplant? The immune system has an important role not only in helping fight infection, but also in protecting the body against cancer. However, in kidney transplant recipients the immune system…

The post Could a new blood test identify rare blood cancer sooner in people with kidney transplants? appeared first on Kidney Research UK.

]]>

Could a new blood test identify rare blood cancer sooner in people with kidney transplants?

10 December 2025

How do rare blood cancers develop after transplant?

The immune system has an important role not only in helping fight infection, but also in protecting the body against cancer. However, in kidney transplant recipients the immune system functions less well owing to the treatments that are needed to prevent rejection of the donated kidney. This makes these patients more vulnerable to certain cancers, including a type of blood cancer called post-transplant lymphoproliferative disease (PTLD) 

The most common cause of PTLD is Epstein-Barr virus. Epstein-Barr virus is common, and most people will be infected in their lifetime. After infection the virus remains in the body, where it is in a harmless, inactive state. In immunosuppressed patients their weakened immune system can mean the virus reactivates, unfortunately this can lead to cancer. 

About PTLD

Around 50 transplant recipients a year in the UK develop PTLD.  The small number of patients with PTLD makes research into outcomes challenging, but limited evidence from case studies of a variety of PTLD patients on different treatments has found survival rates to be around 40-60%. There is an urgent need for earlier diagnosis and treatments to improve outcomes for these patients. 

Head and shoulders photo of Heather, who has her brown hair tied back, rectangle glasses and is wearing a grey blouse and black cardigan.
Dr Heather Long

Meet Dr Heather Long

Dr Heather Long is a researcher at the University of Birmingham looking at the relationship between the immune system, viruses and cancers. The Professor Michael Nicholson research project award of £230,000 will mean Heather can continue her work to identify markers of PTLD in the blood of kidney transplant patients and understand more about how the tumours in PTLD behave.  

“PTLD is hard to identify, and therefore is often diagnosed late, meaning treatment is delayed and the outcomes for patients are not good. There is also an urgent need to develop new treatments for PTLD.

Studying a rare disease is difficult as it’s harder to get the samples and data needed for research. A clinical trial for PTLD led by Birmingham and Newcastle meant we finally had access to the samples needed and this catalysed the start of this research.” Dr Heather Long 

Could a new blood test identify blood cancer development sooner after transplant?

Heather and her team previously collected samples of blood and tumours, alongside clinical data, from PTLD patients taking part in a UK-wide clinical trial. Using these blood samples, they were able to identify several markers found in PTLD patients.

Heather and her team will look at the levels of these markers in another group of kidney transplant patients with PTLD to confirm whether it is possible to detect PTLD from a blood sample.

Heather and the team will also use special technology to measure genes (sections of our inherited code, DNA) in the tumour cells of PTLD patients to study how the tumours prevent the entry of immune cells which helps them evade the immune system.  

Looking for earlier diagnoses and treatments

“I am very grateful to Kidney Research UK and its supporters for helping fund the next stage of our research. We hope that identifying markers in the blood could lead to development of a new routine test for diagnosing PTLD earlier, meaning prompter treatments and better outcomes for patients. By studying the mechanisms by which PTLD tumours avoid the immune system we also hope to identify new treatment targets for more effective therapies in the future.” Dr Heather Long

"We are delighted to be funding Dr Heather Long’s important research at the University of Birmingham which builds on this work funded by Kidney Research UK. This project aligns closely with Rosetrees’ core aim of supporting high-quality medical research that can be translated into real patient benefit.

"By advancing earlier diagnosis and exploring new treatment strategies for post-transplant lymphoproliferative disease (PTLD), Dr Long’s work has the potential to significantly improve outcomes for transplant patients facing this life-threatening complication and may also open new avenues for treating other forms of lymphoma.

"By funding with Kidney Research UK into this disease area we aim to maximise the impact of this ongoing research to improve outcomes for transplant patients who develop this serious condition." Dr Vineeth Rajkumar. Head of Research, Rosetrees

Our latest research news

Why not make a donation now?

Every £ counts towards transforming treatments for people living with kidney disease.

The post Could a new blood test identify rare blood cancer sooner in people with kidney transplants? appeared first on Kidney Research UK.

]]>
Husband’s Rudolph-inspired production line in support of wife waiting for kidney transplant https://www.kidneyresearchuk.org/2025/12/09/husbands-rudolph-inspired-production-line-in-support-of-wife-waiting-for-kidney-transplant/ Tue, 09 Dec 2025 08:00:11 +0000 https://www.kidneyresearchuk.org/?p=160056 Husband’s Rudolph-inspired production line in support of wife waiting for kidney transplant 09 December 2025 A man from West Yorkshire is selling hand-crafted wooden reindeer decorations to raise money in support of his wife’s battle against kidney disease this Christmas, having been told he is incompatible to donate a kidney.  Ian Smith, 59, from Cleckheaton…

The post Husband’s Rudolph-inspired production line in support of wife waiting for kidney transplant appeared first on Kidney Research UK.

]]>

Husband’s Rudolph-inspired production line in support of wife waiting for kidney transplant

09 December 2025

A man from West Yorkshire is selling hand-crafted wooden reindeer decorations to raise money in support of his wife’s battle against kidney disease this Christmas, having been told he is incompatible to donate a kidney. 

Ian Smith, 59, from Cleckheaton in West Yorkshire, was determined to give a kidney to his wife, Ann-Marie (56), when hers failed in 2022. Unfortunately, tests found him to be incompatible, and for the past three years, Ann-Marie has been tied to an exhausting regime of dialysis to stay alive. She remains on the waiting list, alongside nearly 7,000 patients in the UK, hoping for a life-changing kidney transplant. 

A man, woodworking in a shed
Ian, in his shed making the reindeers

Bradford City supporter, Ian, who works for British Gas, says: “I was devastated when I found out I couldn’t donate a kidney to Ann-Marie. It has been very scary seeing her so unwell. Her condition has had a huge impact on our lives, she needs dialysis three times a day. 

“When I was unable to be a kidney donor, I decided to donate my time to make a difference instead.” 

Seeing artisans selling their wares on a visit to York Christmas market last year inspired Ian’s idea to hand-craft wooden reindeer.  

He says: “I set about designing some in my shed and a couple of friends bought them – then I kept getting requests for more!” Ian explains. “They’re all made from tree branches with metal washers for eyes and a Christmas bauble for a nose. Each one has their own character because they’re all different shapes and sizes. Our innovation for the 2025 design is to add scarves knitted by my daughter Amy, keeping the reindeer warm. We’re also trialling some wooden snowman to accompany them.  

“We’ve had lots of interest, and all the proceeds will be donated to Kidney Research UK. It means a lot to us to be able to support life-changing research that could make kidney transplants more readily available in the future. We also hope sharing our story will help to raise awareness of the importance of becoming an organ donor.” 

Ann-Marie's kidney disease

In 2022, Ann-Marie's kidneys failed, after deteriorating over many years. This was caused by a form of hereditary polycystic kidney disease (PKD) which affected Ann-Marie's father and two uncles.  

Ann-Marie says: “I discovered I was living with PKD in my early twenties after being tested because of my family history. I needed an annual check-up to track my kidney function. I had no symptoms and wouldn’t have realised anything was wrong until the check-up showed my kidneys had failed. 

“I was very anxious about starting dialysis because of how much my dad struggled. Thankfully treatment has moved on in the past 30 years, meaning that I can dialyse at home. That has been important in adapting my life to continue working in my accounting job. My consultant and dialysis nurses have been lovely and supportive. 

“Sadly, dialysis does still place a lot of restrictions on life. I’m a very sociable person but I can’t do as much now. I feel so tired and am exhausted by the time I finish work. I am part of a walking group but find it harder to trek long distances. We also love travelling together but it is very difficult to have a holiday now. 

“I am fed up of waiting for a transplant. It’s been three years now. I have to be within two hours of St James’s University Hospital in Leeds at all times, and have a bag packed ready to go if I get the call. It’s really strange waiting for somebody to die before I can get my life back. It’s a sad situation. I hope research can make things like artificial kidneys a possibility, preventing the need for a long waiting lists.” 

Husband and wife, standing in their lounge, dressed for an occasion.
Ann-Marie and Ian Smith

Kidney disease at Christmas

Dialysis will continue to impact Ann-Marie at Christmas until she receives the transplant she has been waiting for.  

Ian says: “We love Christmas. We used to go to Christmas markets across Europe but can’t do that anymore. We don’t go to as many parties or shows with friends either. Ann-Marie struggles with crowds because she worries somebody might bump into her and knock out the tube she needs in her stomach for dialysis.  

“We’ve done our best to make new traditions. Every Christmas Eve we go to the picture house to watch ‘It’s a Wonderful Life’. We’re also bringing the Christmas markets home with the reindeer I am selling to fundraise for Kidney Research UK!”  

Ann-Marie says: “Our two grown-up kids come home for Christmas. I cook for everyone but I’m not able to each as much as I used to. I’m not supposed to eat chocolate, salt or other rich foods, and have to think about my potassium levels. 

“I try to get on with life without putting everything on hold until I have a transplant. We try to maintain a positive outlook and keep each other laughing. Being unwell does make you appreciate life and stop getting annoyed over little things.” 

An uncertain future

It is not clear when Ann-Marie will finally get her transplant. She and Ian also have concerns about how their two children could be affected if they have inherited PKD 

Ann-Marie says: ”Our children have not yet been tested, but it is a worry that they could have PKD like me and their grandad. We’re hoping for the best and supporting research into the disease that will improve future treatment if they do ever need it. I hope I’ll be able to have my transplant soon, although the idea of surgery is scary. I can’t wait to go on holiday abroad again, and be able to do simple things. Like having a bath – which I can’t do because I can’t get my dialysis port wet. Or getting my nails done – I don’t normally wear nail varnish as it has to be removed for surgery, and I don’t want to hold anything up if I get the call.”  

Ian says: "We can see how much research has made a difference since Ann-Marie's dad was on dialysis. I hope our fundraising will continue to help push treatments forward to make a difference for patients in the future.” 

Wooden reindeers made by Ian Smith

Give hope this Christmas

Please support kidney patients, like Ann-Marie, to get back to making happy memories by donating to our Christmas appeal.

6 year old girl sitting on a hospital bed having dialysis.

The post Husband’s Rudolph-inspired production line in support of wife waiting for kidney transplant appeared first on Kidney Research UK.

]]>
Kidney transplant patient discovers three cancerous tumours on bladder https://www.kidneyresearchuk.org/2025/12/08/kidney-transplant-patient-discovers-three-cancerous-tumours-on-bladder/ Mon, 08 Dec 2025 12:09:59 +0000 https://www.kidneyresearchuk.org/?p=160071 Kidney transplant patient discovers three cancerous tumours on bladder The patient featured in this article has chosen to share his story anonymously  08 December 2025 Since receiving a kidney transplant seven years ago, life has not been all plain sailing for a Scottish man in his seventies.  Living with polycystic kidney disease (PKD), he required…

The post Kidney transplant patient discovers three cancerous tumours on bladder appeared first on Kidney Research UK.

]]>

Kidney transplant patient discovers three cancerous tumours on bladder The patient featured in this article has chosen to share his story anonymously 

08 December 2025

Since receiving a kidney transplant seven years ago, life has not been all plain sailing for a Scottish man in his seventies. 

Living with polycystic kidney disease (PKD), he required a transplant in 2018, and his quality of life improved immensely. However, a kidney transplant is not a cure, and his underlying health has remained complicated. 

Just a few months after transplantation, doctors identified a small tumour in his bladder and diagnosed him with BK virus. This common childhood virus usually remains dormant in the kidney and lining of the ureters and bladder. However, it can become active again when the immune system is weakened, such as in patients who need immunosuppressants to prevent kidney rejection post-transplant. 

Kidney Research UK funded researcher, Dr Simon Baker, from the University of York, has found a link between BK virus and bladder cancer, which may help to explain this man’s experience of needing three tumours to be removed from his bladder in the last six years. 

Inherited kidney disease

The man’s family has been deeply affected by polycystic kidney disease (PKD), which has been inherited by generations of his family. 

He says: “When my mum was diagnosed, I knew there was a chance I’d be affected, but it wasn’t until my sixties that I began to have symptoms. I had an extremely painful abdomen which I attributed to appendicitis. However, when I went to A&E, it was discovered that I had a bursting kidney cyst. Doctors revealed that my kidney function was at 20% and I was placed under the care of a renal consultant to monitor my health as my kidneys declined.  

“The effects of kidney disease meant that I had to retire from work. I lost weight, was fatigued, slept more and felt general apathy. I lost my enthusiasm for life. Knowing that my body was shutting down was not nice. I kept walking and gardening as much as I could, but would always need to come inside and have a sleep.” 

Life-changing transplant

In 2018, he received the kidney transplant he’d been waiting for.  

He says: “I was able to receive a kidney through the UK Living Kidney Sharing Scheme, which enabled a transplant to take place as part of a chain, including an altruistic donor. 

“I’m in awe of the sharing scheme. Seven operations happened on the same day to make my transplant possible. It’s an incredible thing to donate a kidney. 

“After my transplant I felt great. It takes a little while to recover from surgery, especially at my age, but I’m pretty active again now. I still need to take medication post-transplant, but I’m quite fit, everything considered.  

“I’m so glad to be here. I’m living my life, having fun, riding my motorcycle and spending time with family. I have a life now that I wouldn’t have had if it wasn’t for my transplant. I know my kidney won’t go on forever, but I won’t go on forever anyway.”  

BK virus and bladder cancer 

A stent was put into his transplanted kidney – where the ureter comes into the bladder – to keep it open while it healed post-transplant. However, when it was removed nine weeks later, doctors found a tiny tumour.  

He says: “Luckily, it was caught early and removed three weeks later. However, within a month, my kidney function declined prompting a biopsy. That led to a diagnosis of BK virus. Although I didn’t experience symptoms, my immunosuppressants had to be reduced to enable my immune system to combat the virus. That left me vulnerable to transplant rejection, but fortunately this was avoided. 

“In the past five years, two further tumours have been identified in my bladder through routine appointments. Both were small and successfully removed – one in 2020 and one in 2023. I feel very fortunate these were discovered early because I never had any symptoms. It’s concerning because I wouldn’t have known anything was wrong.  

“I never realised there could be a link between BK virus and bladder cancer until I came across Dr Simon Baker’s research. In my experience, the two conditions have been treated very separately by different departments in hospital.” 

Simon sat beside is lab bench, with shelves filled with equipment behind him, he is wearing a white lab coat.
Dr Simon Baker

Ongoing research

Dr Simon Baker is studying DNA from bladder cancers, like Tim’s, to understand more about the risk that BK virus poses in these developing. In addition, he co-chaired the development of the first clinical guideline for the management of BK virus with the British Transplantation Society, with the hope of establishing a national screening process to identify infections early.   

Early diagnosis and treatment for bladder cancer has been vital in this case, enabling the removal of three tumours with no long-lasting impact.  

Our kidney patient says: “Without past research which has made transplants and other treatments possible, I would not be here. There is plenty more to discover and I’m only too happy to contribute to research. Kidney disease has affected generations of our family and it’s going to continue. The more it’s talked about and the more that can be done the better.” 

Male and female reserachers, standing side on, looking at microscopes. Both wear green lab coats.

Is bladder cancer caused by BK virus?

Research from Dr Simon Baker’s group at the University of York, suggests that BK virus can trigger changes in DNA that drive bladder cancer development, which kidney transplant recipients are at much greater risk of.

Why not make a donation now?

Every £ counts towards transforming treatments for people living with kidney disease.

The post Kidney transplant patient discovers three cancerous tumours on bladder appeared first on Kidney Research UK.

]]>
New results suggest that bladder cancer could be caused by the body’s response to common childhood virus https://www.kidneyresearchuk.org/2025/12/04/new-results-suggest-that-bladder-cancer-could-be-caused-by-the-bodys-response-to-common-childhood-virus/ Thu, 04 Dec 2025 06:00:38 +0000 https://www.kidneyresearchuk.org/?p=159936 New results suggest that bladder cancer could be caused by the body’s response to common childhood virus 04 December 2025 Data published today in Science Advances, from Dr Simon Baker’s group at the University of York, suggests that BK virus can trigger changes in DNA that drive bladder cancer development, which kidney transplant recipients are…

The post New results suggest that bladder cancer could be caused by the body’s response to common childhood virus appeared first on Kidney Research UK.

]]>

New results suggest that bladder cancer could be caused by the body’s response to common childhood virus

04 December 2025

Data published today in Science Advances, from Dr Simon Baker’s group at the University of York, suggests that BK virus can trigger changes in DNA that drive bladder cancer development, which kidney transplant recipients are at much greater risk of. The study was funded by Kidney Research UK and York Against Cancer.  

Simon sat beside is lab bench, with shelves filled with equipment behind him, he is wearing a white lab coat.
Dr Simon Baker

The impact of BK virus on kidney transplant recipients

BK virus is a common virus that nearly everyone picks up in childhood generally without noticing. Once you have been infected with BK virus, it can hide in the kidneys without causing obvious symptoms. Reactivation of BK virus can happen in kidney transplant recipients due to their immunosuppressive medication. These drugs prevent the immune system from attacking the new kidney, but they also make it harder to fight off infections such as BK virus. 

Reactivated BK virus infection can affect the kidneys, ureter (the tube connecting the kidney to the bladder) and bladder, potentially resulting in kidney damage. When kidney damage occurs, it is known as BK virus-associated nephropathy (BKVAN or BKN), which affects around 5% of transplant recipients. 

Currently there are no specific treatments for BK virus or its complications. Reducing immunosuppressive medication helps the immune system to fight BK virus, but it carries the risk that the immune system might damage the transplanted kidney.  

Kidney transplant recipients face a significantly higher risk of developing bladder and ureter cancers

We know that kidney transplant recipients develop ureter and bladder cancers much more frequently than the general population, linked to BK virus infection. 

“Kidney transplant recipients are at over three times greater risk of bladder cancer. We have suspected that BK virus is involved in bladder cancer in transplant recipients, but little was known about the processes within the body that led to these cancers. Our results not only tell us more about how urinary tract tumours might develop in transplant recipients, but also suggest that BK virus may be involved in cancer development in the rest of the population.” Dr Simon Baker. 

What is bladder cancer? 

The urinary bladder is an organ that stores urine at low pressure to protect the kidneys. Bladder cancer refers to an abnormal growth of cells (tumour) that develops in the bladder lining (known as the “urothelium”). Each year in the UK there are over 23,000 new cases of bladder cancer. 

Dr Simon Baker explains the research in this video

Uncovering the role of enzymes in bladder cancer development

Bladder cancer is caused by DNA damage (“mutations”), leading to changes in genes that can turn healthy cells into cancer. Most of the genomic changes found in bladder cancer cells are related to a group of enzymes called ‘APOBECS’.  

APOBECS help the body fight viruses by damaging viral DNA. Bladder cancer is much more common in smokers, and scientists were expecting to see DNA damage caused by smoke exposure but were surprised to instead find APOBEC mutations. An additional complication that researchers had to explain is why bladder cancers do not normally contain detectable viruses when they are diagnosed. This study helps explain how bladder cancers might end up with so much DNA damage caused by a known antiviral response. 

BK virus reactivation can trigger mutations that drive bladder cancer

In this study, Dr Simon Baker and the team at the University of York took cells from the urothelium and performed controlled exposures to BK virus, analysing the pattern of DNA damage caused by the viral infection over a period of weeks and months in the laboratory.  

An image of the APOBEC enzymes. The background is black, with blue blobs all over the image, alongwith a cluster of bright green blobs and pink areas.
BK virus infection of the human urothelium (the tissue that lines the urinary tract) show APOBEC enzymes are shown in red and infected cells in green. Importantly the red cells with APOBEC enzymes were often found not to contain any green, indicating that APOBEC enzymes were acting in cells that were not infected. The blue colour is a DNA stain, and each spot is the nucleus, the part of a cell where its DNA is stored.

For the first time, they saw patterns of changes in the DNA of human cells that were very similar to the way that BK virus DNA is damaged as part of an antiviral response. This damage to host cell and viral DNA is caused by part of the cell’s antiviral weaponry known as “APOBEC” enzymes. Simon’s results provide evidence suggesting that BK virus infections drive an increased risk of bladder cancer in kidney transplant patients through the action of these DNA damaging APOBEC enzymes.  

Simon added “In other types of virus-related cancer, such as cervical cancer, we know that virus DNA combines with our own genetic material to drive tumour development. Our results have shown that in the bladder, the tissue’s defensive response to the virus causes DNA changes which can lead to cancer. We found that DNA damage happens not only in infected cells but also in surrounding bystander cells” witnessing infection in their neighbours. This DNA damage to uninfected cells could help explain why bladder cancers normally show no trace of viruses when they are diagnosed years later. 

David Crosby, chief research officer at Kidney Research UK commented: These findings strongly suggest that we should be taking the management of BK virus seriously to support health of kidney transplant patients. We are delighted to be supporting Simon to undertake further research in this area which could lead to the development of new treatment options for at-risk patients.  

Patients at the heart of research

My research is inspired by kidney transplant recipients. Kidney disease is a very difficult condition to live well with, and we want to ensure that when someone receives a donated kidney, they enjoy the best health possible, for as long as possible. My Kidney Research UK fellowship has allowed us to better understand how the BK virus may be driving bladder cancer so that we can find new treatments that will allow us to control this virus and reduce the risk of bladder cancer and BK virus-associated nephropathy in the future.

When I started my fellowship, I was surprised to find there was no widely available evidence-based patient information and that clinical practice in managing BK virus infections across the UK was very variable. I have been really pleased over the fellowship to have been involved in drafting a patient information leaflet and contributing to the first UK Guideline on BK virus management for the British Transplantation Society. These additional activities help my fundamental research to have more immediate impacts for patients.” Dr Simon Baker.  

staff and students in a group shot in the lab, all are wearing white lab coats.
Dr Simon Baker and team
Tim, in the garden, taking a selfie smiling for the camera.

What impact does BK virus reactivation have on patients?

Tim Tavender had a kidney transplant in 2015, shortly afterwards his health deteriorated due to BK virus and, subsequently, bladder cancer.  

Why not make a donation now?

Every £ counts towards transforming treatments for people living with kidney disease.

The post New results suggest that bladder cancer could be caused by the body’s response to common childhood virus appeared first on Kidney Research UK.

]]>